Hidradenitis Suppurativa: Update on Diagnosis and Treatment
691069106910hidradenitis suppurativaWhat has been your most challenging condition to treat? I’d be willing to bet that hidradenitis suppurativa (HS) would be at least one (if not the top) answer.  The pain/suffering that HS patients endure brings me to tears sometimes.  Do you share this sentiment?  If so, I hope to empower you with practical pearls from Dr. Adam Friedman, Professor and Interim Chair of Dermatology, Residency P …
hidradenitis suppurativa
A Practical Approach to Atypical Nevi
668766876687atypical neviDespite being one of the more common reasons for consulting a dermatologist, the diagnosis and management of atypical nevi remain nuanced and can often be challenging. I had the opportunity to learn from Dr. Jean Bolognia on her approach to atypical nevi, and walked away with many pearls to share. 1. Identify the patient’s signature nevus and come up with a plan. Sometimes it can be overwhelmi …
atypical nevi
Tofacitinib Therapeutic Cheat Sheet
661566156615Welcome to our new series, Therapeutic Cheat Sheet, wherein we take a deep dive into the literature and guidelines to give you a quick reference on the use of new or complex therapies.  This series will become your go-to for information about dosing, potential interactions and laboratory monitoring, just to name a few.  First up: Tofacitinib. [caption id="attachment_6617" align="aligncenter" …
Pathophysiology and Management of Rosacea: Pearls from the Expert
660066006600rosaceaIf you’re a coffee drinker, you may be relieved to know that there was an inverse association between caffeine intake and risk of rosacea in a recent study.  That was a huge relief for me for sure! Unfortunately, we can’t prescribe caffeine for rosacea and call it a day. So, what works? High-yield pearls on the pathophysiology and management of rosacea are shared by Dr. Adam Friedman � …
rosacea
The Appropriate Management of Actinic Keratoses and Squamous Cell Carcinoma
639663966396actinic keratosesIn a 20-minute lecture presented at the 16th Annual ODAC conference, Dr. Patel reviewed the appropriate management of actinic keratoses and squamous cell carcinoma. Grabbing the attention of the audience early on, Dr. Patel quoted the staggering statistics for squamous cell carcinoma – calling the growing epidemic “a public health crisis.”  He challenged dermatologists to lead the charge in …
actinic keratoses